Breast cancer Posts Page 2 on Medivizor
Navigation Menu

Breast cancer Posts on Medivizor

Update on guidelines for the use of adjuvant chemotherapy and targeted therapy in breast cancer patients.

Posted by on Aug 5, 2017 in Breast cancer | 0 comments

In a nutshell This report summarized updates made to the guidelines for treatment of HER2-positive breast cancer with adjuvant chemotherapy and targeted therapy.  Some background Adjuvant chemotherapy (treatment after surgery) is often used to prevent cancer recurrence. Chemotherapy involves agents that work to kill cancer cells in the body....

Read More

Fulvestrant: an option for estrogen-receptor positive breast cancer that has spread

Posted by on Aug 5, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to compare fulvestrant (Faslodex) to other standard endocrine agents in patients with advanced hormone sensitive breast cancer. This study concluded that fulvestrant was as effective as the available standard endocrine agents.  Some background Advanced hormone sensitive breast cancer (BC) is cancer that has...

Read More

Can exercise help breast cancer survivors?

Posted by on Aug 1, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to examine the effect of physical activity on cognitive function in breast cancer survivors. This study concluded that physical activity may have a positive impact on cognitive function in breast cancer survivors.  Some background Breast cancer survivors can often suffer from cognitive impairment. Cognitive...

Read More

Guidelines for the use of hormone therapy in hormone receptor-positive patients with metastatic breast cancer.

Posted by on Aug 1, 2017 in Breast cancer | 0 comments

In a nutshell This report aimed to develop recommendations for endocrine therapy in women with hormone receptor-positive metastatic breast cancer. Some background Endocrine therapy, also known as hormone therapy (HT) is used to treat hormone receptor (HR) positive metastatic breast cancer (MBC). HR positive MBC depends on the hormones estrogen or...

Read More

Is abemaciclib combined with fulvestrant effective in women with HR positive advanced breast cancer?

Posted by on Jul 15, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to compare the effectiveness of the combination of fulvestrant (Faslodex) and abemaciclib to fulvestrant alone in patients with advanced breast cancer. This study concluded that the combination of fulvestrant and abemaciclib had improved outcomes for patients when compared to fulvestrant alone.  Some background...

Read More

Are beta blockers useful in advanced breast cancer?

Posted by on Jun 5, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate the association between beta blocker use and outcomes in HER2 negative breast cancer (BC) patients. This study concluded that beta blocker use leads to improved progression free survival in BC patients.  Some background Beta blockers are therapies used to treat various heart related conditions....

Read More

The impact of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on BC survival

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether beta blockers (BB), angiotensin-converting enzyme inhibitors (ACEi), and angiotensin receptor blockers (ARB) have a beneficial effect on breast cancer-specific survival (BCSS; the time between diagnosis and death from BC). The use of BB was found to be associated with better BCSS survival. Some...

Read More